Welcome to our dedicated page for Koninklijke Phil news (Ticker: PHG), a resource for investors and traders seeking the latest updates and insights on Koninklijke Phil stock.
Koninklijke Philips N.V. reports health technology developments across Diagnosis & Treatment, Connected Care and Personal Health. News from Royal Philips commonly covers order intake and comparable sales trends; product launches and regulatory clearances for imaging, image-guided therapy and AI software; and governance actions from its Annual General Meeting. Recent product themes include CT platforms such as Rembra and Spectral CT Verida, interventional guidance tools such as DeviceGuide and IntraSight Plus, and the Bridge Plus Occlusion Balloon for lead extraction procedures.
The company’s updates also address hospital monitoring, informatics, ultrasound, oral health and personal-care lines. Coverage reflects Philips’ role as a Netherlands-based global health technology company with securities traded on NYSE under PHG and on Euronext Amsterdam under PHIA.
Royal Philips (NYSE: PHG) launched the Pediatric Coaching Solution to minimize stress for children undergoing MRI scans. This innovative approach utilizes gamification and a ‘buddy system’ to prepare children, aiming to reduce the use of general anesthesia and enhance patient experiences. The solution includes a mobile app for familiarization with MRI procedures and interactive engagements at the hospital, significantly improving scan quality and potentially lowering healthcare costs. The launch occurs at the International Pediatric Radiology Congress in Rome, with plans for broader applications across different imaging modalities.
On October 4, 2021, Radboud university medical center announced a significant achievement in lung cancer diagnostics using Philips technology. The clinical study reported a 90% diagnostic accuracy in identifying lung cancer through navigation bronchoscopy, leveraging the Philips Lung Suite and Azurion system. Additionally, the average radiation dose per procedure was reduced by over half, from 47.5 Gy·cm2 to 25.4 Gy·cm2. This advancement marks a potential turning point in early lung cancer detection, significant given the high mortality rate associated with the disease.
Royal Philips (NYSE: PHG) has achieved a global consensus from 40 medical experts regarding the use of intravascular ultrasound (IVUS) in peripheral vascular disease (PVD) interventions. The consensus aims to standardize IVUS application to enhance patient care quality. The findings were presented at the Vascular Interventional Advances (VIVA) 2021 symposium. Philips emphasizes the importance of IVUS in delivering tailored treatment plans and improving patient outcomes, underlining its leadership in health technology and commitment to evidence-based guidelines.
Royal Philips (NYSE: PHG) has entered a five-year strategic partnership with Main Line Health to enhance cardiovascular care in Philadelphia. This collaboration aims to integrate advanced cardiovascular solutions, optimizing patient data and workflows, while ensuring cost predictability. The partnership will equip Main Line Health's facilities, including Bryn Mawr and Paoli Hospitals, with state-of-the-art Philips technology, enhancing their ability to deliver high-quality care. Both parties will focus on clinical, operational, and business model innovations to improve patient outcomes and experiences.
Royal Philips has successfully completed the sale of its Domestic Appliances business to Hillhouse Investment for approximately EUR 4.4 billion. The deal includes an enterprise value of EUR 3.7 billion, with cash proceeds after tax of around EUR 3 billion. This transaction will be reported under discontinued operations in Q3 2021. Philips aims to strengthen its remaining Personal Health business, valued at EUR 3.2 billion, focusing on healthy living and disease prevention through innovative solutions. The divestment aligns with Philips' strategy to optimize its health technology portfolio.
Philips Avent, a top global brand for mother and childcare products, has introduced several innovative items aimed at enhancing infant care. New products include the Philips Avent Natural Baby Bottle with a Natural Response Nipple, designed to mimic breastfeeding, the Philips Avent Soothie Heart, a pacifier that supports natural oral development, and the Philips Avent Double Electric Breast Pump, Advanced, which features Natural Motion Technology for efficient milk flow. These offerings reflect over five years of research to meet parental needs.
Royal Philips (NYSE: PHG) has announced an update regarding the recall of specific sleep and respiratory care devices due to potential health risks from a foam component. Most affected units are in the U.S., with over 80% being first-generation DreamStation devices. The FDA has authorized the rework of these devices to replace the problematic foam, with repairs expected to start in September 2021. Philips aims to complete this process within 12 months and has initiated replacement programs in other countries, enhancing production and outreach to affected patients.
Summary not available.
Royal Philips (NYSE: PHG) announced the launch of its innovative digital experience at the European Society of Cardiology (ESC) 2021 Congress. The comprehensive suite of cardiac care solutions aims to enhance patient outcomes through early detection, accurate diagnosis, and efficient treatment. Philips emphasizes the growing challenge of cardiovascular diseases and highlights its leadership in integrated imaging, devices, and informatics. Key innovations showcased include the Philips Spectral CT 7500, advanced ultrasound technologies, and comprehensive cardiology informatics to improve clinical decision-making and efficiency.
Philips Sonicare has launched a unique partnership with NYC-based fashion brand Susan Alexandra to create a limited-edition travel accessory line. The collaboration focuses on self-expression with vibrant designs, featuring the Philips One by Sonicare toothbrush. The first product, a playful beaded lip charm, is available for $48, while additional items like a toiletry case and tote bag are set to launch in September 2021. This initiative aims to attract young adults prioritizing health and individuality in their travel routines.